PatchSiren cyber security CVE debrief
CVE-2026-87286 Oracle Corporation CVE debrief
A vulnerability in Oracle GraalVM product of Oracle Java SE (component: Compiler) allows unauthenticated attackers with network access via HTTP to compromise Oracle GraalVM, potentially leading to takeover. The supported version affected is Oracle GraalVM: 25.0.4.1. This CVE was published on 2026-09-15T20:19:18.560Z and was last modified on 2026-09-22T04:18:01.753Z.
- Vendor
- Oracle Corporation
- Product
- Oracle GraalVM
- CVSS
- HIGH 8.1
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-09-15
- Original CVE updated
- 2026-09-22
- Advisory published
- 2026-09-15
- Advisory updated
- 2026-09-22
Who should care
Defenders responsible for Oracle GraalVM deployments, particularly those with network exposure, should assess and mitigate this vulnerability. This includes operators managing Oracle GraalVM instances, platform administrators, vulnerability management teams, and security teams responsible for ensuring the security of Oracle GraalVM deployments.
Why it matters
Defenders should prioritize verifying exposure of Oracle GraalVM version 25.0.4.1 and assessing network access controls due to the potential for unauthenticated attackers to compromise the system.
- Potential takeover of Oracle GraalVM instances
- Exposure of sensitive data through compromised Oracle GraalVM
- Disruption of services due to Oracle GraalVM compromise
- Need for verification of Oracle GraalVM version and exposure
Technical summary
The vulnerability in Oracle GraalVM product of Oracle Java SE (component: Compiler) allows unauthenticated attackers with network access via HTTP to compromise Oracle GraalVM. Successful attacks can result in takeover of Oracle GraalVM. The CVSS 3.1 Base Score is 8.1 (Confidentiality, Integrity and Availability impacts). This vulnerability affects Oracle GraalVM version 25.0.4.1, and defenders should prioritize verifying exposure and assessing network access controls to mitigate potential impacts on confidentiality, integrity, and availability.
Defensive priority
Defenders should prioritize verifying exposure of Oracle GraalVM version 25.0.4.1 and assessing network access controls.
Recommended defensive actions
- Verify Oracle GraalVM version 25.0.4.1 is not exposed to untrusted networks
- Assess and restrict network access to Oracle GraalVM
- Review and apply Oracle's security updates for Oracle GraalVM
- Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up
- Review compensating controls for exposed systems while remediation is scheduled and verified
- Check relevant monitoring, detection, and logs for exposed assets that need extra review
- Track exceptions, retest remediated assets, and close the item only after evidence is documented
Evidence notes
The CVE record and NVD entry provide details on the vulnerability in Oracle GraalVM. Oracle's security alert documentation is referenced but not examined in detail. Defenders should verify exposure of Oracle GraalVM version 25.0.4.1 and assess network access controls due to potential for unauthenticated attackers to compromise the system. Evidence limits suggest focusing on CVE and NVD details for now.
Sources and references
Verified primary and authoritative sources
-
CVE-2026-87286 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-87286
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-87286 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-87286
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
Source reference
Unverified legacy reference
URL: https://www.oracle.com/security-alerts/oracle-open-source-cves-outside-other-oracle-public-documents.html
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.